HCV
  • Featured content
    Led by Norah Terrault, MD, MPH, a panel of experts including Gregory Dore, MBBS, PhD, FRACP, MPH; Graham R. Foster, FRCP, PhD; and Ira M. Jacobson, MD, provides an overview of the current state of HCV therapy, emphasizing the unprecedented levels of efficacy and simplicity in curing individual patients, and discusses important strategies for eliminating HCV infection across communities and ultimately throughout the world.
  • Featured content
    In this downloadable slideset, Sherilyn C. Brinkley, MSN, CRNP; Jordan J. Feld, MD, MPH; Jason Grebely, BSc, PhD; Nancy Reau, MD, FAASLD, AGAF; and Phoebe Sebhatu, PharmD, BCPS, review best practices in addressing practical aspects of managing patients with HCV, including interpretation of current guidelines and payer policies, approaches to patient education and engagement in care, specialty pharmacy utilization and navigation of the insurance appeals process, and management of drug users and patients who become reinfected.
    Date Posted: 11/28/2016
  • Featured content
    Listen to this downloadable audio from a live Webinar in which an expert faculty member discusses the clinical impact of new data reported at the Barcelona meeting.
    Date Posted: 6/1/2016
  • Featured content
    In this downloadable slideset, Ira M. Jacobson, MD, reviews the newest regimens and data for genotype 1 HCV infection.
    Date Posted: 6/1/2016
  • Featured content
    In this Interactive Case Challenge, Paul Y. Kwo, MD, explores important considerations when selecting all-oral HCV therapy for patients with cirrhosis.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 937 Shown
10 of 937 Shown
Show 10 More
Loading...